ArticleJournal of nanobiotechnology2021

Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model.

María Merino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.